Breakthrough Asthma Treatment: First New Option in 50 Years Hailed

3 hours ago

Breakthrough Asthma Treatment: First New Option in 50 Years Hailed
Generated image for illustrative purposes:

7 Highlights

  • Benralizumab is a promising new asthma treatment, the first in 50 years.
  • King's College London led a study on benralizumab in 2024.
    • The drug targets eosinophils to reduce lung inflammation globally.
    • Eosinophils play a key role in asthma and COPD attacks.
    • Initial trials on 158 patients showed fewer treatment failures than steroids.
    • Benralizumab may be safer with fewer side effects compared to steroids.
    • Further trials are needed for large-scale application of benralizumab.
0 Comments

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Related Articles

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.